All articles tagged with #sjogrens disease
Novartis announced positive results from its Phase III trials of ianalumab, demonstrating significant improvement in disease activity for Sjögren’s disease, potentially making it the first targeted treatment for this autoimmune disorder. The trials showed the drug was well tolerated and could soon be submitted for regulatory approval.
A new AI model analyzing salivary gland biopsies can predict vital organ involvement in Sjögren’s patients with high accuracy, potentially aiding early diagnosis and treatment decisions, though further validation is needed.
Dry mouth, gums, and lips can be symptoms of Sjogren's disease, an autoimmune disease that affects the secretory glands. There is a connection between Sjogren's disease and severe COVID-19 infections, with COVID-19 potentially triggering the development of Sjogren's disease. While there is limited long-term data on the prognosis of Sjogren's disease following COVID-19, it is possible that the dry mouth symptoms may improve over time. However, it is more likely that the COVID-19 infection induced Sjogren's disease, which may be permanent. Rheumatologists are the experts for Sjogren's disease, and there are various treatments available. Additionally, there is no evidence to suggest that the COVID-19 vaccine reduces sensitivity to pollen allergies.